National Storage Mechanism | Additional information 
RNS Number : 2567C
Tate & Lyle PLC
06 October 2025
Tate & Lyle PLC
Notification of transactions by Persons Discharging Managerial Responsibilities
Tate & Lyle PLC (the 'Company') has been informed that on 6 October 2025 the following transaction occurred by a Person Discharging Managerial Responsibilities ('PDMR') and a person closely associated ('PCA') in respect of their purchase of ordinary shares of 29 1/6 pence each in the capital of the Company ('Shares').
PDMR
Number of shares acquired
Price per Share
Steve Foots (PDMR) and Alison Foots (PCA)
£3.699547
The notification below, which has been made in accordance with the requirements of the Market Abuse Regulation, provide further detail.
Matthew Joy
Company Secretary
6 October 2025
Notification and public disclosure of transaction by person discharging managerial responsibilities
Details of PDMR / person closely associated with them ("PCA")
a)
Name
Steve Foots (PDMRS) and Alison Foots (PCA)
2.
Reason for the notification
a)
Position / status
Non-executive Director and a person closely associated
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Tate & Lyle PLC
b)
LEI
2138008K14474WPKZ244
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument
Identification code
Ordinary shares of 29 1/6 pence each in the capital of Tate & Lyle PLC
GB00BP92CJ43
b)
Nature of the transaction
Acquisition of Shares
c)
Price(s) and volume(s)
|
|
| Price per Share |
Volume(s) |
| £3.699547 |
16,000 |
d)
Aggregated information
- Aggregated volume
- Price
16,000 Shares
£59,193.232
e)
Date of the transaction
6 October 2025
f)
Place of the transaction
London Stock Excchange
XLON
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHUNUVRVVURRAA